APYX CIK: 719135

Apyx Medical Corp

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
60.7
FY22:
43.0
FY23:
70.4
FY24:
56.4
FY25:
58.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
7.98
FY22:
8.80
FY23:
8.88
FY24:
8.40
FY25:
8.37
Total assets
Change from FY21 to FY25
millions USD
FY21:
68.7
FY22:
51.8
FY23:
79.2
FY24:
64.8
FY25:
66.8

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
13.2
FY22:
11.9
FY23:
12.7
FY24:
10.7
FY25:
11.7
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.51
FY22:
2.13
FY23:
39.6
FY24:
39.8
FY25:
40.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
53.7
FY22:
37.6
FY23:
26.7
FY24:
14.2
FY25:
14.5
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
68.4
FY22:
51.6
FY23:
79.0
FY24:
64.7
FY25:
66.5

All amounts in millions USD Data sources:SEC EDGARTwelve Data